Abstract. Depressive disorder is a mental health disorder caused by the dysfunction of nerve regeneration, neuroendocrine and neurobiochemistry, which frequently results in cognitive impairments and disorder. Evidence has shown that resveratrol offers benefits for the treatment of depressive disorder. In the present study, the therapeutic effects of resveratrol were investigated and the potential mechanisms mediated by resveratrol were analyzed in hippocampal neuron cells. The anti-oxidative stress and anti-inflammatory properties of resveratrol were also examined in vitro and in vivo. The results revealed that resveratrol administration inhibited the inflammation in hippocampal neuron cells induced by ouabain. Oxidative stress in the hippocampal neuron cells was ameliorated by resveratrol treatment in vitro and in vivo. In addition, the apoptosis of hippocampal neuron cells was inhibited by the upregulation of anti-apoptotic genes, including P53, B-cell lymphoma-2 (Bcl-2) and Bcl-2-associated death promoter, and the downregulation of the cleaved caspase-3 and caspase-9. The analysis of the mechanism revealed that that resveratrol treatment suppressed the apoptosis of hippocampal neuron cells through the NETRIN1-mediated extracellular signal-regulated kinase/cAMP signal transduction pathway. The results of the in vivo assay showed that resveratrol treatment led to improvements in cognitive competence, learning memory ability and anxiety in a mouse model of depressive disorder induced by ouabain. In conclusion, these results indicated that resveratrol treatment had protective effects against oxidative stress and neuroinflammatory pathogenesis through the NETRIN1-mediated extracellular signal-regulated kinase/cAMP signal transduction pathway, suggesting that resveratrol treatment may be a potential antidepressant agent for the treatment of depressive disorder.
Introduction
Currently, depressive disorder is adding to the global burden of disease, and has been considered to be a major public health concern with a genetic cause (1, 2) . A systematic review has showed that neurostimulatory and ablative treatment options are important in cognitive impairments in pathological processes in depressive disorder (3) . Clinical investigations have found that depressive disorder can aggravate the pathological symptoms associated with cardiovascular and cerebrovascular diseases, and can cause increased disability and distress (4) . Although the use of antidepressants for the treatment of depression, in addition to mindfulness-based therapies, technology-assisted self-help and minimal contact therapies, have been described in systematic reviews and meta-analysis (5, 6) , the potential mechanisms of the pathological processes in depressive disorder have also been investigated and discussed (7, 8) .
It has been suggested that neurobiological treatments may be efficacious for depression through structural and functional alterations to the prefrontal cortex, hippocampus and amygdala in the brain (9) (10) (11) . Resveratrol is a multifunctional biological polyphenol, which has ameliorative effects on high concentrations of inflammatory factors, metabolic syndrome and neurological diseases (12, 13) . A study by O'Donovan et al indicated that suicidal ideation is associated with elevated inflammation in patients with major depressive disorder (14) . Previous reports have also demonstrated that resveratrol can effectively inhibit endothelial degeneration and prevent the production of tumor necrosis factor α in patients with coronary artery disease (15) , and has also shown beneficial effects in patients with chronic kidney disease through the downregulation of nuclear factor erythroid 2-related factor 2 and nuclear factor-κB in a randomized, double-blind, placebo-controlled, crossover clinical trial (16) . In addition, Rodrigues et al described the potential association between oxidative stress and genetic vulnerability in major depressive disorder and Alzheimer's disease (17) , and the effects of oxidative and nitrosative stress in accelerated aging and major depressive disorder have also been discussed in a previous study (18) .
In the present study, the benefits of resveratrol for depressive disorder were investigated in hippocampal neuron cells and in a mouse model of depressive disorder. The potential mechanisms mediated by resveratrol for inflammation, apoptosis and oxidative stress were also analyzed in hippocampal neuron cells, and cognitive impairments from pathological processes were examined in the depressive disorder mouse model induced by ouabain. The overall findings suggested that resveratrol treatment inhibited the apoptosis of hippocampal neuron cells through regulation of the NETRIN1-mediated extracellular signal-regulated kinase/cAMP signal transduction pathway in the treatment of depressive disorder.
Materials and methods
Ethics statement. The present study was performed in accordance with the recommendations in the Guide for the Care Cell culture and reagents. Resveratrol was purchased from Merck Millipore (Darmstadt, Germany) and was made up to a solution of 100 mg/ml with PBS. The hippocampal neuron cells were isolated from the experimental mice with depression as described previously (19) and cultured in Dulbecco's modified Eagle's medium supplied with 10% fetal bovine serum (Merck Millipore). The cells were cultured at 37˚C in a humidified atmosphere of 95% air and 5% CO 2 .
Western blot analysis. The hippocampal neuron cells were harvested by scraping and lysing in RIPA buffer, which followed homogenization at 4˚C for 10 min. Protein concentration was measured using a bicinchoninic assay protein assay kit (Thermo Fisher Scientific, Inc., Waltham, MA, USA). Protein (10 µg) was analyzed using 12% SDS-PAGE assays followed by transfer onto a polyvinylidene fluoride membranes (Merck Millipore). Thermo Fisher Scientific, Inc.) according to the manufacturer's protocol. The siRNA targeting NETRIN1 (sense, 5'-CUU AGC UAG CCA UAU UCC UUC CA-3'; antisense, 5'-AUA UCG UGU AAC UCG UCU AGA U-3') and scrambled siRNA (sense, 5'-AUC ACG UAC GCG GAA UAC UUC GA-3'; antisense, 5'-UCG AAG UAU UCC GCG UAC GUG AU-3') were obtained from GenePharma (Shanghai, China).
Terminal deoxynucleotidyl transferase (TdT)-mediated dUTP nick-end labeling (TUNEL) assay.
To analyze the apoptosis of hippocampal neuron cells in the experimental mice following treatment with resveratrol (10 mg/kg) or the same dose of PBS, a TUNEL assay (Biotool, Houston, TX, USA) was used to detect TUNEL-positive cells. The procedures were performed as described in a previous study (20) . Finally, images of the hippocampal neuron cells were captured with a ZEISS LSM 510 confocal microscope (Zeiss AG, Oberkochen, Germany) at 488 nm.
Animal experiments. Female J20 mice (6-8 weeks old, 25-32 g body weight) were purchased from Jackson Laboratory (Ben Harbor, ME, USA) and bred at Tongji Hospital, Huazhong University of Science and Technology (Wuhan, China). All animals were housed at 23±1˚C and a relative humidity of 50±5%, with a 12-h light/dark cycle and free access to food and water. The experimental mice were used to establish depressive disorder model mice via intravenously injecting 5ml ouabain (10 -3 M) once a week for 7 weeks consecutively. The mice were separated into two groups (n=20 in each group). The experimental mice were treated with a single daily oral dose of resveratrol (10 mg/kg) for 10 weeks or with the same dose of PBS as a control.
Assessment of depressive behavior. The efficacy of simvastatin treatment for depressive disorder was determined using the open field test, elevated plus maze, Barnes maze performance, object recognition, and passive avoidance experiments. These experiments were performed according to methods described in previous reports (21, 22) .
Enzyme-linked immunosorbent assay (ELISA).
The serum levels of IL-8 (cat. no. KHC0081; Thermo Fisher Scientific, Inc.), IL-1β (cat. no. MBS700340; Thermo Fisher Scientific, Inc.), IL-17A (cat. no. 88-7876-88; Thermo Fisher Scientific, Inc.), H3R (cat no. orb154346; Biorbyt, Cambridge, UK) and TNF-α (cat. no. KHC3014; Thermo Fisher Scientific, Inc.), were detected in mice with depressive disorder prior to and following treatment with resveratrol using ELISA kits according to the manufacturer's protocol. Finally, the serum concentration levels of IL-8, IL-1β, IL-17A and TNF-α were measured using an enzyme microplate reader at 450 nm.
Statistical analysis.
The results are presented as the mean ± standard error of the mean. Significance was established with SPSS 19.0 (IBM Corp., Armonk, NY, USA) and GraphPad Prism 6 software (GraphPad Software, Inc., La Jolla, CA, USA). A Kaplan-Meier plot, log-rank test, multi-variant Cox regression analysis, Pearson's correlation coefficient and a two-tailed Student's t-test were used. P<0.05 was considered to indicate a statistically significant difference.
Results

Resveratrol treatment inhibits inflammatory cytokines in serum and hippocampal neuron cells in experimental mice.
Inflammatory cytokines are crucial in the progression of depressive disorder. Therefore, the present study investigated the expression levels of inflammatory cytokines. The results showed that resveratrol treatment downregulated the plasma concentrations of IL-1β, IL-17A, IL-8 and TNF-α (Fig. 1A) . The expression levels of these inflammatory cytokines were also decreased by resveratrol in hippocampal neuron cells, determined using western blot analysis (Fig. 1B) . These results suggested that resveratrol treatment inhibited inflammatory cytokines in the mouse depressive disorder model.
Resveratrol decreases oxidative stress in hippocampal neuron cells in experimental mice.
Oxidative stress parameters are important prognostic indicators following therapy for patients with depressive disorder (23) . The data obtained in the present study showed that the production of SOD and GSH were decreased by resveratrol in the hippocampal neuron cells (Fig. 2A) . As shown in Fig. 2B , the expression levels of NEG and CAT were also downregulated by resveratrol in the hippocampal neuron cells. The immunohistochemistry showed that cyclooxygenase-2 was decreased by resveratrol in the hippocampal neuron cells (Fig. 2C) . ELISA results also revealed that the serum levels of H3R were significantly lower following treatment with resveratrol (Fig. 2D) . These results suggested that resveratrol treatment decreased oxidative stress in the hippocampal neuron cells of the experimental mice.
Resveratrol suppresses the apoptosis of hippocampal neuron cells in a mouse model of depressive disorder.
The present study analyzed the apoptosis of hippocampal neuron cells in a mouse model of depressive disorder following resveratrol treatment. As shown in Fig. 3A , the apoptotic rate was suppressed in the resveratrol-treated hippocampal neuron cells. The protein expression levels of anti-apoptotic P53 and Bcl-2 were upregulated by resveratrol treatment in the hippocampal neuron cells (Fig. 3B) . Resveratrol treatment downregulated the protein expression levels of pro-apoptotic cleaved caspase-3 and caspase-9 in the hippocampal neuron cells (Fig. 3C) . The viability of the hippocampal neuron cells was also improved by resveratrol treatment (Fig. 3D) . These results suggested that resveratrol suppressed the apoptosis of hippocampal neuron cells in the mouse model of depressive disorder.
Resveratrol regulates apoptosis of hippocampal neuron cells through the NETRIN1-mediated extracellular signal-regulated kinase/cAMP signal transduction pathway.
The potential mechanism underlying the resveratrol-regulated apoptosis of hippocampal neuron cells was examined. As shown in Fig. 4A , the expression levels of NETRIN1 and NRG3 were increased in the hippocampal neuron cells treated with resveratrol. The administration of resveratrol inhibited the activity and expression of cAMP in the hippocampal neuron cells (Fig. 4B and C) . The knockdown of NETRIN1 (siNETRIN1) eliminated the resveratrol-induced inhibition (siNET-RS) of the activity and expression of cAMP in the hippocampal neuron cells (Fig. 4D and E) . Apoptosis was also increased in the NETRIN1-knockdown hippocampal neuron cells following treatment with resveratrol (Fig. 4F) , and the effects on the gene expression levels of P53, Bcl-2, cleaved caspase-3 and caspase-9 were also reversed in the resveratrol-treated hippocampal neuron cells ( Fig. 4G and H) . These results suggested that resveratrol regulated the apoptosis of hippocampal neuron cells through the NETRIN1-mediated extracellular signal-regulated kinase/cAMP signal transduction pathway.
Resveratrol administration ameliorates depressive behaviors in mice with depressive disorder induced by ouabain. The present study further analyzed the therapeutic efficacy of resveratrol on the mouse model induced by ouabain. As shown in Fig. 5A , resveratrol treatment relieved anxiety, which was determined by the time spent in the center. The resveratrol-treated mice showed increased movement and took less time to recognize a novel object, compared with the control mice (Fig. 5B and C) . In addition, the body weights of the mice were improved following resveratrol treatment, compared with the control group (Fig. 5D) . Collectively, these results suggested that resveratrol treatment ameliorated depressive behaviors. 
Discussion
Depressive disorder presents with an increasing trend of a number of biological psychological factors and frequently co-occurs with other psychiatric problems (24, 25) . Evidence indicates that inflammation and apoptosis contribute to the initiation and development of depressive disorder, and are regarded as prognostic indicators in the treatment of depression (26, 27) . Previously, it has been shown that resveratrol can ameliorate depressive-like behavior in repeated corticosterone-induced depression in mice (28) . However, the potential mechanisms underlying the resveratrol-mediated beneficial effects in hippocampal neuron cells remain to be fully elucidated. The present study investigated the therapeutic effects of resveratrol in mice with depressive disorder induced by ouabain, and examined the molecular mechanism mediated by resveratrol in hippocampal neuron cells. The findings suggested that resveratrol administration ameliorated the depressive behaviors in the mice with depressive disorder induced by ouabain. This occurred by the inhibition of hippocampal neuron cell apoptosis through the NETRIN1-mediated extracellular signal-regulated kinase/cAMP signal transduction pathway.
Inflammatory cytokines and depression are closely associated as inflammation induces the symptoms of depression and depressed mood, and favors stress, indicating the ability of inflammation to induce symptoms of depression (29) . Kohler et al showed that anti-inflammatory treatments are efficient for patients with depression, and attributed to learning and memory ability (30, 31) . Resveratrol has been shown to attenuate inflammation via the modulation of intracellular GSH homeostasis in the processes of atherosclerosis and ischemic brain injury in aged female mice (32, 33) . In the present study, the results showed that resveratrol treatment inhibited inflammatory cytokines in the hippocampal neuron cells isolated from mice with depressive disorder.
The oxidative stress and nitrosative stress pathways in major depression may contribute to the degenerative processes in the hippocampal region (34) . Oxidative stress and inflammatory markers also have been associated with depression and nicotine dependence (35) . A study by Mathieu et al indicated that resveratrol attenuated oxidative stress in mitochondrial complex I deficiency through regulation of the sirtuin 3 signaling pathway (36) . In the present study, it was observed that resveratrol treatment attenuated oxidative stress in hippocampal neuron cells, which may have contributed to the recovery in depressive disorder.
The apoptosis of hippocampal neuron cells impairs cognition and increases anxiety in patients with depressive disorder (37, 38) . It has been demonstrated that resveratrol treatment can inhibit testicular dysfunction and apoptosis via involvement of the p38 mitogen-activated protein kinase/activating transcription factor 2/inducible nitric oxide synthase signaling pathway (39) . Resveratrol has also been reported to improve hippocampal atrophy in mice with chronic fatigue by enhancing neurogenesis and inhibiting the apoptosis of granular cells (40) . In the present study, the results of the analyses suggested that resveratrol treatment inhibited the apoptosis of hippocampal neuron cells. Examination of the potential mechanism indicated that resveratrol regulated the apoptosis of hippocampal neuron cells through the NETRIN1-mediated extracellular signal-regulated kinase/cAMP signal transduction pathway, which is constant with previous reports (41,42).
In conclusion, the results of the present study demonstrated that inflammation and oxidative stress are involved in the pathological processes of depressive disorder. Notably, these findings demonstrated the importance of anti-apoptotic effects on hippocampal neuron cells for protecting against cognitive impairments in the mouse model of depression induced by ouabain. The results also suggested that inhibition of the NETRIN1-mediated extracellular signal-regulated kinase/cAMP signal transduction pathway mediated by resveratrol contributed to cognitive repair and decreased anxiety in the experimental mice.
